Sestamibi MBI There is no relevant literature to support the use of the use of Tc-99m sestamibi MBI as the next step in evaluating a palpable mass with suspicious sonographic features in women <30 years of age. Variant 8: Adult female, younger than 30 years of age. Palpable breast mass. US findings probably benign (BI-RADS 3). Next imaging study. Digital Breast Tomosynthesis Diagnostic If a correlate for a palpable mass has been identified on US and is probably benign, there is no indication for DBT to further evaluate the palpable mass in women <30 years of age. Digital Breast Tomosynthesis Screening In women presenting with signs or symptoms, including a palpable breast mass, screening DBT, with or without DM, is unnecessary for imaging surveillance. Screening mammography is provided to women without signs or symptoms of breast disease. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast dedicated in women <30 years of age with probably benign sonographic findings in the setting of a palpable mass [2]. Image-Guided Core Biopsy Breast If a palpable mass has probably benign features as identified on US, US follow-up is recommended. However, image-guided core biopsy may be performed after complete imaging assessment in some cases. For example, BI- RADS 3 lesions in high-risk patients, patients awaiting organ transplant, patients with known synchronous cancers, or patients trying to get pregnant may be appropriate for biopsy instead of imaging follow-up. In addition, situations in which biopsy may alleviate extreme patient anxiety may prompt tissue sampling and a biopsy marker clip should be placed [30]. Image-Guided Fine Needle Aspiration Breast If a palpable mass has probably benign features as identified on US, US follow-up is recommended. Image-guided FNAB may be performed after complete imaging assessment in some cases.
Palpable Breast Masses. Sestamibi MBI There is no relevant literature to support the use of the use of Tc-99m sestamibi MBI as the next step in evaluating a palpable mass with suspicious sonographic features in women <30 years of age. Variant 8: Adult female, younger than 30 years of age. Palpable breast mass. US findings probably benign (BI-RADS 3). Next imaging study. Digital Breast Tomosynthesis Diagnostic If a correlate for a palpable mass has been identified on US and is probably benign, there is no indication for DBT to further evaluate the palpable mass in women <30 years of age. Digital Breast Tomosynthesis Screening In women presenting with signs or symptoms, including a palpable breast mass, screening DBT, with or without DM, is unnecessary for imaging surveillance. Screening mammography is provided to women without signs or symptoms of breast disease. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast dedicated in women <30 years of age with probably benign sonographic findings in the setting of a palpable mass [2]. Image-Guided Core Biopsy Breast If a palpable mass has probably benign features as identified on US, US follow-up is recommended. However, image-guided core biopsy may be performed after complete imaging assessment in some cases. For example, BI- RADS 3 lesions in high-risk patients, patients awaiting organ transplant, patients with known synchronous cancers, or patients trying to get pregnant may be appropriate for biopsy instead of imaging follow-up. In addition, situations in which biopsy may alleviate extreme patient anxiety may prompt tissue sampling and a biopsy marker clip should be placed [30]. Image-Guided Fine Needle Aspiration Breast If a palpable mass has probably benign features as identified on US, US follow-up is recommended. Image-guided FNAB may be performed after complete imaging assessment in some cases.